Arizona State Retirement System Invests $139,000 in Orthofix Medical Inc. (NASDAQ:OFIX)

Arizona State Retirement System bought a new stake in shares of Orthofix Medical Inc. (NASDAQ:OFIX) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 10,471 shares of the medical device company’s stock, valued at approximately $139,000.

Several other institutional investors also recently bought and sold shares of OFIX. GSA Capital Partners LLP acquired a new position in shares of Orthofix Medical during the first quarter worth $921,000. Engine Capital Management LP acquired a new position in Orthofix Medical during the 4th quarter valued at about $40,916,000. Boone Capital Management LLC purchased a new stake in Orthofix Medical in the fourth quarter valued at about $6,740,000. Charles Schwab Investment Management Inc. boosted its holdings in Orthofix Medical by 7.5% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 461,885 shares of the medical device company’s stock worth $6,226,000 after acquiring an additional 32,400 shares in the last quarter. Finally, Dynamic Technology Lab Private Ltd purchased a new stake in shares of Orthofix Medical during the fourth quarter worth about $239,000. 89.76% of the stock is currently owned by institutional investors and hedge funds.

Orthofix Medical Stock Performance

OFIX opened at $16.14 on Thursday. The company has a market cap of $605.72 million, a P/E ratio of -4.78 and a beta of 1.05. The company has a quick ratio of 1.13, a current ratio of 2.48 and a debt-to-equity ratio of 0.24. The firm’s 50-day moving average price is $16.38 and its 200-day moving average price is $14.67. Orthofix Medical Inc. has a 52-week low of $9.57 and a 52-week high of $17.67.

Orthofix Medical (NASDAQ:OFIX) last released its earnings results on Tuesday, August 6th. The medical device company reported ($0.88) earnings per share for the quarter, missing the consensus estimate of ($0.30) by ($0.58). The company had revenue of $198.62 million for the quarter, compared to analysts’ expectations of $195.75 million. Orthofix Medical had a negative return on equity of 20.68% and a negative net margin of 15.61%. As a group, equities analysts anticipate that Orthofix Medical Inc. will post -2.13 EPS for the current fiscal year.

Orthofix Medical Profile

Orthofix Medical Inc operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions.